COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.76
+4.62%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+5.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 9, 2026 | Pavao Mark H · director | A-Award | 10,000 | $4.53 |
| Jan 26, 2026 | Grossman Fred · officer: Chief Medical Officer | A-Award | 140,041 | $4.73 |
| Jan 26, 2026 | Berman Howard · director, officer: Executive Chairman | A-Award | 15,257 | $4.73 |
| Jan 26, 2026 | Swaminathan Arun · director, officer: Chief Executive Officer | A-Award | 293,983 | $4.73 |
| Jan 26, 2026 | SNYDER DAVID S · officer: Chief Financial Officer | A-Award | 140,041 | $4.73 |
| Jan 6, 2026 | GOLDSTEIN DOV A MD · director | A-Award | 10,000 | $5.65 |
| Jan 6, 2026 | Weinand Dieter · director | A-Award | 10,000 | $5.65 |
| Jan 6, 2026 | ROSS WILBUR L JR · director | A-Award | 10,000 | $5.65 |
| Jan 6, 2026 | Lee Ann · director | A-Award | 10,000 | $5.65 |
| Jan 6, 2026 | Villalobos Anabella · director | A-Award | 10,000 | $5.65 |
| Aug 19, 2025 | GOLDSTEIN DOV A MD · director | M-Exempt | 17,557 | $1.09 |
| Feb 25, 2025 | Villalobos Anabella · director | A-Award | 5,000 | $5.97 |
| Feb 25, 2025 | GOLDSTEIN DOV A MD · director | A-Award | 5,000 | $5.97 |
| Feb 25, 2025 | Weinand Dieter · director | A-Award | 5,000 | $5.97 |
| Feb 25, 2025 | ROSS WILBUR L JR · director | A-Award | 5,000 | $5.97 |
| Feb 25, 2025 | Lee Ann · director | A-Award | 5,000 | $5.97 |
| Jan 13, 2025 | Swaminathan Arun · director, officer: Chief Executive Officer | A-Award | 240,964 | $6.07 |
| Jan 13, 2025 | Grossman Fred · officer: Chief Medical Officer | A-Award | 140,562 | $6.07 |
| Jan 13, 2025 | Berman Howard · director | A-Award | 150,602 | $6.07 |
| Jan 13, 2025 | SNYDER DAVID S · officer: Chief Financial Officer | A-Award | 140,562 | $6.07 |
| Jan 3, 2025 | ROSS WILBUR L JR · director | A-Award | 5,000 | $5.73 |
| Jan 3, 2025 | Lee Ann · director | A-Award | 5,000 | $5.73 |
| Jan 3, 2025 | Villalobos Anabella · director | A-Award | 5,000 | $5.73 |
| Jan 3, 2025 | Weinand Dieter · director | A-Award | 5,000 | $5.73 |
| Jan 3, 2025 | GOLDSTEIN DOV A MD · director | A-Award | 5,000 | $5.73 |
| Nov 14, 2024 | SNYDER DAVID S · officer: Chief Financial Officer | Purchase | 1,800 | $7.19 |
| Nov 13, 2024 | Swaminathan Arun · director, officer: Chief Executive Officer | Purchase | 5,000 | $7.36 |
| Nov 12, 2024 | Grossman Fred · officer: Chief Medical Officer | Purchase | 2,710 | $7.37 |
| Nov 12, 2024 | Swaminathan Arun · director, officer: Chief Executive Officer | Purchase | 5,000 | $7.34 |
| Jun 5, 2024 | SNYDER DAVID S · officer: Chief Financial Officer | A-Award | 70,596 | $8.15 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 19Reduced 14Sold out 56
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DME CAPITAL MANAGEMENT, LP | Increased | 2,335,540 | May 15, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Unchanged | 975,404 | Apr 30, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 844,913 | May 15, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 800,000 | May 15, 2026 |
| PROSIGHT MANAGEMENT, LP | New Position | 420,360 | May 15, 2026 |
| CM MANAGEMENT, LLC | Increased | 375,000 | May 8, 2026 |
| PRIVATE MANAGEMENT GROUP INC | Increased | 369,096 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 233,402 | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 225,792 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 139,886 | May 8, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 103,964 | May 14, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | Increased | 101,330 | May 15, 2026 |
| JBF CAPITAL, INC. | Unchanged | 100,006 | May 8, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 95,919 | May 7, 2026 |
| MORGAN STANLEY | Reduced | 85,700 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 9, 2026